Lai, C-C <br/><br/>
Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  Feb 2015 
 - 601-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-014-2910-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Adult<br/>Biomarkers--blood<br/>Bone Diseases, Metabolic--complications<br/>Bone Remodeling--drug effects<br/>Case-Control Studies<br/>Cross-Sectional Studies<br/>Cyclosporine--pharmacology<br/>Female<br/>Fibroblast Growth Factor-23<br/>Fibroblast Growth Factors--blood<br/>Glucocorticoids--pharmacology<br/>Humans<br/>Immunosuppressive Agents--pharmacology<br/>Lumbar Vertebrae--diagnostic imaging<br/>Lupus Erythematosus, Systemic--complications<br/>Male<br/>Middle Aged<br/>Osteoporosis--complications<br/>Premenopause<br/>Treatment Outcome